Of note, data showing that CSF1-R and c-Kit receptor inhibitor masitinib could prevent SC reactivity in degenerating nerves and ameliorate sciatic nerve pathology in ALS rats [196] provide an opportunity for pharmacological treatment of vestibular schwannomas. Here, CSF1R is linked to amyotrophic lateral sclerosis.